产品展示
优质供应
详细内容
SW-13（肾上腺皮质腺癌细胞 ）
上海义森生物科技有限公司
ATCC® Number: CCL-105™ Designations: SW-13 Depositors: A Leibovitz Biosafety Level: 1 Shipped: frozen Medium & Serum: See Propagation
SW-13（肾上腺皮质腺癌细胞 ）
上海义森生物科技有限公司
ATCC® Number: CCL-105™ Designations: SW-13 Depositors: A Leibovitz Biosafety Level: 1 Shipped: frozen Medium & Serum: See Propagation
SW-13（肾上腺皮质腺癌细胞 ）
上海义森生物科技有限公司
| ATCC® Number: | CCL-105™ |
| Designations: | SW-13 |
| Depositors: | A Leibovitz |
| Biosafety Level: | 1 |
| Shipped: | frozen |
| Medium & Serum: | See Propagation |
SW-13（肾上腺皮质腺癌细胞 ）
上海义森生物科技有限公司
SW-13（肾上腺皮质腺癌细胞 ） Growth Properties: adherent Organism: Homo sapiens （human） Morphology: epithelial Source: Organ: adrenal gland Tissue: cortex Tumor Stage: grade IV Disease: primary small cell carcinoma Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. Isolation: Isolation date: August, 1971
上海义森生物科技有限公司
